Skip to content
10-Q

Quarterly Report

CROSS COUNTRY HEALTHCARE INC CCRN

0001628280-26-032542

← back to feed
Filed
May 8, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 24, 2026 32.33M sh
Shares Diluted Q1 2026 · Mar 31, 2026 31.47M sh
Shares Diluted Q1 2026 · Mar 31, 2025 32.28M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $5.87M
Stock Repurchased Q1 2026 · Mar 31, 2025 $314K
Capex Q1 2026 · Mar 31, 2026 $1.46M
Capex Q1 2026 · Mar 31, 2025 $1.89M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $4.77M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $5.68M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $105.58M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $108.74M
Stockholders Equity Q1 2026 · Mar 31, 2026 $312.81M
Stockholders Equity Q1 2026 · Dec 31, 2025 $322.82M
Stockholders Equity Q1 2026 · Mar 31, 2025 $418.21M
Stockholders Equity Q1 2026 · Dec 31, 2024 $418.96M
Current Liabilities Q1 2026 · Mar 31, 2026 $90.57M
Current Liabilities Q1 2026 · Dec 31, 2025 $77.76M
Total Liabilities Q1 2026 · Mar 31, 2026 $138.27M
Total Liabilities Q1 2026 · Dec 31, 2025 $126.13M
Current Assets Q1 2026 · Mar 31, 2026 $298.3M
Current Assets Q1 2026 · Dec 31, 2025 $293.59M
Total Assets Q1 2026 · Mar 31, 2026 $451.07M
Total Assets Q1 2026 · Dec 31, 2025 $448.95M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.14
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.02
Eps Basic Q1 2026 · Mar 31, 2026 −$0.14
Eps Basic Q1 2026 · Mar 31, 2025 −$0.02
Sga Expense Q1 2026 · Mar 31, 2026 $45.81M
Sga Expense Q1 2026 · Mar 31, 2025 $52.49M
Net Income Q1 2026 · Mar 31, 2026 −$4.27M
Net Income Q1 2026 · Mar 31, 2025 −$490K
Operating Income Q1 2026 · Mar 31, 2026 −$4.16M
Operating Income Q1 2026 · Mar 31, 2025 −$977K
Revenue Q1 2026 · Mar 31, 2026 $241.06M
Revenue Q1 2026 · Mar 31, 2025 $293.41M